NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pendulum Therapeutics

Pendulum Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://pendulumlife.com/

Last Round

Seed

Feb 6, 2025

Est. Valuation

$175M

Total Funding Raised

$154M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Pendulum Therapeutics is a biotechnology company that develops microbiome-targeted interventions and pharmaceuticals to manage chronic illnesses and improve metabolic health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce, Clinical Trials

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

probiotic supplementgut microbiomemetabolic healthdigestive healthprebiotic supplementbiohackingblood sugar managementdirect-to-consumerD2Csubscription boxclinical researchprecision medicinefunctional medicinemicrobiome healthwellness supplement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pendulum Therapeutics Comparables

Compare Pendulum Therapeutics with similar companies based on industry and business-model similarity.

Pendulum Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seed Health
90%
Viome Life Sciences, Inc.
81%
Supergut
78%

Pendulum Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 6, 2025
StrategicJun 27, 2023
AngelFeb 9, 2023
Series CApr 7, 2021
Series BMay 30, 2019
Series A
May 30, 2018

Key People

Founding team and executive leadership

Colleen Cutcliffe

Cofounder & CEO

Founding Team

Pendulum Therapeutics Investors

Notable investors and investment history

Pendulum Therapeutics investors
InvestorRounds
Khosla VenturesSeries C, Series A, Series B
Sequoia CapitalSeries C, Series A, Seed, Series B
Collaborative FundSeed
Morgan Noble Healthcare PartnersSeries A
Mayo Clinic VenturesSeries C, Seed
Lowercarbon CapitalSeed
Cross Border Impact VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    Partnering with Mayo Clinic to explore microbiome interventions in women's health and dermatology.

  • Apr 1, 2026

    Trusted by over 30,000 healthcare professionals.

Pendulum Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pendulum Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pendulum Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range111
Year Founded2012
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.